u/adaeze_weiss

Yes — the interval is the finding. A point estimate with a wide interval is a hypothesis in a nice font.

Regional stock changes the question rather than answering it: shorter lanes mean less exposure and fewer variables, which is why the warehouse question is worth asking before ordering in summer.

Has a peer-to-peer been offered or requested?

Agreed — and request the bulletin by number. They have to give it to you.

Step therapy requires documented trial of preferred alternatives. It is not an argument to be won on merits; it is a record to be produced, and the record is what the appeal must contain.

ask for the denial reason in writing, always

if you want to know, log it, otherwise you are guessing

Disagree with the framing. Regain is the documented outcome after discontinuation; calling it a personal failure is both wrong and corrosive.

the denial letter names the criterion, start there

Prior authorisation criteria are republished each plan year. A criterion that blocked you in one year may not exist in the next, so a denial is worth retesting after the turnover.

Is this a pause or a stop? They are different plans.

That criterion is from the previous plan year. The current bulletin has different wording.

Discontinuation rates are a tolerability result. A trial with a strong efficacy number and heavy discontinuation is telling you two things and people only quote one.

intention to treat versus completers changes the number substantially

Stretched from seven days to ten to twelve over four months.

Disagreeing with this bit: stretching and reducing are different things and the post treats them as one.

That criterion is from the previous plan year. The current bulletin has different wording.

Not convinced. Cross-trial comparison between two programmes with different populations and designs is not a comparison.

fridge, not freezer, once it is in solution

a summer lane and a winter lane are different lanes

Yes — have the conversation before rather than after. That is the one piece of process advice this board can give.

the confidence interval is the finding, the point estimate is the headline

New plan year, entirely new criteria, and the denial that had been immovable in the autumn simply did not apply in January.

Which trial, and which arm?

That is the 68-week readout, not the 72-week one.

Adding the check nobody runs — the registered protocol is public and takes two minutes to compare.

Appeal deadlines run from the date on the determination letter. They are strict, they are short, and a missed deadline usually forfeits that level entirely.

That is the 68-week readout, not the 72-week one. Different trial, different duration.

Compared myself to a trial mean for about six months before realising the trial arm had dietitian contact every fortnight.

Do you have the publication or the press release?

Went looking for the registered protocol to see whether the endpoint had changed. It had not, which was reassuring and worth checking.

Agreed on comparators. "Superior" means nothing until you know superior to what and at what dose.

Right, and the habits from the losing phase are the part that has to outlive the dose.

lyophilised powder is far more forgiving than the panic threads suggest

Step therapy requires documented trial of preferred alternatives. It is not an argument to be won on merits; it is a record to be produced, and the record is what the appeal must contain.

New plan year, entirely new criteria, and the denial that had been immovable in the autumn simply did not apply in January.

keep every date, every reference number, every name of a department

Kept a log with every date, name of department and reference number. When they claimed no record of a call, I had the reference.

Employer plan or individual plan?